Mechanisms of Cellular Activation in the Antiphospholipid Syndrome
暂无分享,去创建一个
[1] K. McCrae,et al. Extracellular Vesicles in the Antiphospholipid Syndrome , 2017, Seminars in Thrombosis and Hemostasis.
[2] U. Walter,et al. Cofactor‐independent human antiphospholipid antibodies induce venous thrombosis in mice , 2016, Journal of thrombosis and haemostasis : JTH.
[3] C. Mineo,et al. ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice , 2016, Arthritis & rheumatology.
[4] G. Canaud,et al. AKT/mTORC pathway in antiphospholipid-related vasculopathy: a new player in the game , 2015, Lupus.
[5] K. Lackner,et al. Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome , 2015, Thrombosis and Haemostasis.
[6] D. Isenberg,et al. Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis , 2014, Rheumatology.
[7] J. Chapman,et al. IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome. , 2014, Journal of autoimmunity.
[8] V. Richard,et al. Role of Toll‐like Receptors 2 and 4 in Mediating Endothelial Dysfunction and Arterial Remodeling in Primary Arterial Antiphospholipid Syndrome , 2014, Arthritis & rheumatology.
[9] C. Mineo,et al. Genetic variants of ApoE and ApoER2 differentially modulate endothelial function , 2014, Proceedings of the National Academy of Sciences.
[10] B. Furie,et al. Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS. , 2014, Blood.
[11] E. Kruithof,et al. NF‐κB is activated from endosomal compartments in antiphospholipid antibodies‐treated human monocytes , 2014, Journal of thrombosis and haemostasis : JTH.
[12] N. Beglova,et al. Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome. , 2014, Blood.
[13] Hong Zhou,et al. The role of TLR4 in pathophysiology of antiphospholipid syndrome‐associated thrombosis and pregnancy morbidity , 2014, British journal of haematology.
[14] G. Canaud,et al. Inhibition of the mTORC pathway in the antiphospholipid syndrome. , 2014, The New England journal of medicine.
[15] Kazuo Umezawa,et al. The NF-κB specific inhibitor DHMEQ prevents thrombus formation in a mouse model of antiphospholipid syndrome. , 2013, Journal of nephropathology.
[16] D. Waisman,et al. Annexin A2 Heterotetramer: Structure and Function , 2013, International journal of molecular sciences.
[17] K. Lackner,et al. Endosomal NADPH-oxidase is critical for induction of the tissue factor gene in monocytes and endothelial cells , 2013, Thrombosis and Haemostasis.
[18] G. Valesini,et al. Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. , 2012, Blood.
[19] G. Vargas,et al. C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies , 2012, Lupus.
[20] H. Schild,et al. A Role for Toll-Like Receptor Mediated Signals in Neutrophils in the Pathogenesis of the Anti-Phospholipid Syndrome , 2012, PloS one.
[21] P. Massari,et al. The Role of TLR2 in Infection and Immunity , 2012, Front. Immun..
[22] I. Giles,et al. Examining how antiphospholipid antibodies activate intracellular signaling pathways: a systematic review. , 2012, Seminars in arthritis and rheumatism.
[23] K. McCrae,et al. A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies. , 2012, Blood.
[24] H. Schild,et al. Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cells. , 2011, Blood.
[25] E. Kruithof,et al. Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. , 2011, Blood.
[26] B. Furie,et al. β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. , 2011, Blood.
[27] P. D. de Groot,et al. Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. , 2011, Blood.
[28] P. D. de Groot,et al. Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. , 2011, The Journal of clinical investigation.
[29] P. D. de Groot,et al. The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study , 2009, Journal of thrombosis and haemostasis : JTH.
[30] K. Hajjar,et al. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. , 2009, Blood.
[31] C. Sommer,et al. In Vitro Effects of Antiphospholipid Syndrome‐IgG Fractions and Human Monoclonal Antiphospholipid IgG Antibody on Human Umbilical Vein Endothelial Cells and Monocytes , 2009, Annals of the New York Academy of Sciences.
[32] J. Brosens,et al. ORIGINAL ARTICLE: Antiphospholipid Antibodies Induce a Pro‐Inflammatory Response in First Trimester Trophoblast Via the TLR4/MyD88 Pathway , 2009, American journal of reproductive immunology.
[33] E. Topol,et al. Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis. , 2009, Thrombosis research.
[34] Hiroshi Deguchi,et al. Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells , 2009, Proceedings of the National Academy of Sciences.
[35] K. McCrae,et al. Annexin A2: biology and relevance to the antiphospholipid syndrome , 2008, Lupus.
[36] N. Mackman,et al. Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule , 2008, Lupus.
[37] P. Meroni,et al. Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome , 2008, Lupus.
[38] N. Mackman,et al. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. , 2008, The Journal of clinical investigation.
[39] R. Derksen,et al. Platelet activation by dimeric β2‐glycoprotein I requires signaling via both glycoprotein Ibα and apolipoprotein E receptor 2′ , 2008, Journal of thrombosis and haemostasis : JTH.
[40] H. Xiong,et al. Endothelial Cell Annexin A2 Regulates Polyubiquitination and Degradation of Its Binding Partner S100A10/p11* , 2008, Journal of Biological Chemistry.
[41] P. D. de Groot,et al. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. , 2008, Blood reviews.
[42] L. Wei,et al. Annexin A2 Regulates the Levels of Plasmin, S100A10 and Fascin in L5178Y Cells , 2008, Cancer investigation.
[43] G. Valesini,et al. Anti-β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts , 2007 .
[44] R. Derksen,et al. Platelets express three different splice variants of ApoER2 that are all involved in signaling , 2007, Journal of thrombosis and haemostasis : JTH.
[45] S. Pierangeli,et al. C5a Receptor‐Deficient Mice Are Protected from Thrombophilia and Endothelial Cell Activation Induced by Some Antiphospholipid Antibodies , 2007, Annals of the New York Academy of Sciences.
[46] P. D. de Groot,et al. Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. , 2007, Blood.
[47] E. Kruithof,et al. The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. , 2007, Blood.
[48] Xiaowei Liu,et al. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies , 2007, Annals of the rheumatic diseases.
[49] P. May,et al. The LDL receptor‐related protein (LRP) family: An old family of proteins with new physiological functions , 2007, Annals of medicine.
[50] B. Božič,et al. Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-beta2-glycoprotein I and anti-annexin A5 antibodies. , 2007, Rheumatology.
[51] Hong Zhou,et al. Involvement of annexin A2 in anti-beta2GPI/beta2GPI-induced tissue factor expression on monocytes. , 2007, Cell research.
[52] G. Valesini,et al. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. , 2007, Arthritis and rheumatism.
[53] N. Laird,et al. Polymorphism in maternal LRP8 gene is associated with fetal growth. , 2006, American journal of human genetics.
[54] W. Schneider,et al. Reconstitution of the Reelin Signaling Pathway in Fibroblasts Demonstrates that Dab1 Phosphorylation Is Independent of Receptor Localization in Lipid Rafts , 2006, Molecular and Cellular Biology.
[55] Xiaowei Liu,et al. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. , 2005, Arthritis and rheumatism.
[56] K. McCrae,et al. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. , 2005, Blood.
[57] P. D. de Groot,et al. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. , 2005, Blood.
[58] S. Akira,et al. Toll-like receptor downstream signaling , 2004, Arthritis research & therapy.
[59] E. Svenungsson,et al. Decreased Binding of Annexin V to Endothelial Cells: A Potential Mechanism in Atherothrombosis of Patients With Systemic Lupus Erythematosus , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[60] J. Salmon,et al. Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation , 2004, Nature Medicine.
[61] S. Akira,et al. Functions of toll-like receptors: lessons from KO mice. , 2004, Comptes rendus biologies.
[62] S. Pierangeli,et al. Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies. , 2004, Thrombosis research.
[63] J. Lambris,et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. , 2003, The Journal of clinical investigation.
[64] P. D. de Groot,et al. Dimers of β2-Glycoprotein I Increase Platelet Deposition to Collagen via Interaction with Phospholipids and the Apolipoprotein E Receptor 2′* , 2003, Journal of Biological Chemistry.
[65] Pojen P. Chen,et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. , 2003, The American journal of pathology.
[66] A. Mantovani,et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. , 2003, Blood.
[67] B. Brachvogel,et al. Annexin A5 Is Not Essential for Skeletal Development , 2003, Molecular and Cellular Biology.
[68] F. Velasco,et al. The role of tissue factor in the antiphospholipid syndrome. , 2001, Arthritis and rheumatism.
[69] B. Beutler,et al. Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies , 2001, Journal of endotoxin research.
[70] S. Akira,et al. Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.
[71] E. Babiychuk,et al. Annexins in Cell Membrane Dynamics , 2000, The Journal of cell biology.
[72] K. McCrae,et al. High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II* , 2000, The Journal of Biological Chemistry.
[73] G. Schmitz,et al. Analysis of Prothrombotic Effects of two Human Monoclonal IgG Antiphospholipid Antibodies of Apparently Similar Specificity , 2000, Thrombosis and Haemostasis.
[74] J. Hanly,et al. Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome. , 2000, Clinical and experimental immunology.
[75] F. Velasco,et al. Increased Levels of Tissue Factor mRNA in Mononuclear Blood Cells of Patients with Primary Antiphospholipid Syndrome , 1999, Thrombosis and Haemostasis.
[76] D. Riddell,et al. rapid communication Identification and characterization of LRP8 (apoER2) in human blood platelets , 2022 .
[77] K. Lackner,et al. Isolation and characterization of two human monoclonal anti-phospholipid IgG from patients with autoimmune disease. , 1999, Journal of autoimmunity.
[78] H. Schwarz,et al. Analysis of Cd44-Containing Lipid Rafts , 1999, The Journal of cell biology.
[79] S. Akira,et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.
[80] E. Rusinova,et al. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon. , 1998, Blood.
[81] G. Hughes,et al. Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. , 1998, Arthritis and rheumatism.
[82] F. Luan,et al. Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. , 1998, Arthritis and rheumatism.
[83] R. Parton,et al. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function , 1998, Nature.
[84] Brisson,et al. Growth of Protein 2-D Crystals on Supported Planar Lipid Bilayers Imaged in Situ by AFM. , 1998, Journal of structural biology.
[85] N. Rote,et al. Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. , 1997, American journal of obstetrics and gynecology.
[86] J. Rand,et al. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism. , 1997, The New England journal of medicine.
[87] G. Hughes,et al. Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. , 1997, Arthritis and rheumatism.
[88] J. Benz,et al. Annexins: from structure to function. , 1997, Biological chemistry.
[89] D. Waisman,et al. Tyrosine Phosphorylation of Annexin II Tetramer Is Stimulated by Membrane Binding* , 1997, The Journal of Biological Chemistry.
[90] J. Barker,et al. Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies. , 1996, Circulation.
[91] Y. Shoenfeld,et al. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. , 1994, Journal of immunology.
[92] J. Barquinero,et al. Effect of Human IgG Antiphospholipid Antibodies on an In Vivo Thrombosis Model in Mice , 1994, Thrombosis and Haemostasis.
[93] W Baumeister,et al. Three-dimensional structure of membrane-bound annexin V. A correlative electron microscopy-X-ray crystallography study. , 1994, Journal of molecular biology.
[94] G. Rodgers,et al. Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. , 1993, American journal of obstetrics and gynecology.
[95] H. Hemker,et al. Clustering of lipid-bound annexin V may explain its anticoagulant effect. , 1992, The Journal of biological chemistry.
[96] C. Tsai,et al. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. , 1992, Annals of the rheumatic diseases.
[97] Y. Shoenfeld,et al. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[98] J. Freyssinet,et al. Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. , 1991, Journal of molecular biology.
[99] M. Mitchell,et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. , 1990, American journal of obstetrics and gynecology.
[100] K. Fujikawa,et al. Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family. , 1988, Biochemistry.
[101] K. Fujikawa,et al. Human placental anticoagulant protein: isolation and characterization. , 1987, Biochemistry.